جست‌وجوی استاد و پژوهشگر

Andrew C. Shinمشاهده پروفایل

استادیار

• Metabolic Health
• Neuroendocrinology
• Branched-Chain Amino Acid (BCAA) Metabolism
• +۵ مورد دیگر

Andrew C. Shin is an Assistant Professor at Texas Tech University within the Department of Nutritional Sciences . His work bridges metabolic health , neuroendocrinology , and neurodegenerative diseases , with a focus on how the brain regulates glucose homeostasis , BCAA metabolism , and bariatric surgery mechanisms . Ph.D. in Neuroscience, Michigan State University (2008) Postdoctoral Fellow, Pennington Biomedical Research Center and Icahn School of Medicine at Mount Sinai Dr. Shin’s research explores the neural pathways involved in appetite regulation , nutrient partitioning , and metabolic resistance . His NIH-funded projects investigate insulin signaling in POMC neurons , BCAA dynamics , and nicotine’s metabolic effects . Recent work highlights the role of the autonomic nervous system in BCAA regulation and its implications for obesity and diabetes . His 15 most recent publications reflect a focus on AI applications in nutrition , BCAA-related pathologies , Alzheimer’s disease , and metabolic surgery outcomes . Key themes include neuroendocrine control , nutritional interventions , and environmental impacts on metabolism . Scientific Awards NIH K01 Award Dr. Shin directs the Mouse Metabolic Phenotyping Facility and collaborates on synbiotic trials for cognitive aging . His work spans basic science and translational research , addressing metabolic disorders and their neurological consequences .

Liu Yeمشاهده پروفایل

استاد

• Sustainable Environmental Engineering
• Greenhouse Gas Mitigation
• Biological Wastewater Treatment
• +۵ مورد دیگر

Liu Ye is a Professor at The University of Queensland (UQ) within the School of Chemical Engineering. She leads the Greenhouse Gas (GHG) research program at UQ Urban Water Engineering and has secured over AU$10M in competitive research funding. Her work focuses on achieving net-zero emissions through innovations in urban wastewater systems, with collaborations spanning 15+ water utilities, governments, and technology firms like Suez and Veolia. Research Areas: Greenhouse gas mitigation, sludge minimization, biogas production, advanced biological nutrient removal, online process control, and resource recovery from wastes. Key Awards: Research Innovation Award (Australia Water Association), UQ Foundation Research Excellence Award, EAIT Faculty Teaching Excellence Award, and Fellow of the Royal Society of Chemistry (RSC). Teaching: Courses include CHEE2020 (Process Equipment and Control), CHEE2501 (Environmental Systems Engineering I), CHEE4012 (Industrial Wastewater Management), and thesis supervision. Leadership: Associate Editor for Environmental Science: Water Research and Technology , member of IWA Strategic Council, and contributor to industry peak bodies like WSAA and WaterRA. Recent Articles: Her 2025 publications highlight strategies for balancing energy recovery with GHG emissions, systematic frameworks for N2O quantification, and advancements in phosphorus removal. Earlier works (2024–2022) explore electrochemical iron applications, ferric salt enhancements, and hybrid modeling techniques combining mechanistic and deep learning approaches. Scientific Impact: Her research has driven a 35% reduction in N2O emissions at an Adelaide treatment plant, saving $50M annually, and pioneered free nitrous acid (FNA) technology for biofilm control and sludge reduction.

Carrie R Ferrarioمشاهده پروفایل

دانشیار

• Neurobiology of motivation
• Obesity research
• Addiction neuroscience
• +۲ مورد دیگر

Dr. Carrie R. Ferrario is a dual-appointed Associate Professor at the University of Michigan, holding positions in both the Medical School's Department of Pharmacology and the College of Literature, Science, and the Arts Department of Psychology . She leads the Ferrario Lab, which investigates the neurobiological intersections of obesity and drug addiction, focusing on glutamatergic transmission in the striatum. Education : Postdoctoral Fellow at University of Michigan Medical School (2012) and Rosalind Franklin University of Medicine and Science (2008) Research Focus : Her work integrates addiction neuroscience, learning theory, and feeding behavior to explore how sugary/fatty foods alter brain function, particularly in relation to individual susceptibility to obesity and parallels between eating urges and substance abuse mechanisms. Scientific Awards : 2023 John J. Abel Award in Pharmacology Collaborations : Co-Director of the NIDA-funded Biology of Drug Abuse Postdoctoral T32 program, with affiliations in the Domino Addiction Research Center, Neuroscience Graduate Program, and Multidisciplinary Training Program in Basic Diabetes Research. Her lab employs advanced behavioral and neurochemical analyses to study motivation and plasticity in obesity and addiction contexts.

• Epigenetic Mechanisms
• Drug Discovery
• Target Discovery
• +۷ مورد دیگر

Professor Udo Oppermann serves as Professor of Molecular Biology and Director of Laboratory Sciences at the Institute of Musculoskeletal Sciences, Botnar Research Centre, University of Oxford. He is also Deputy Director of the Oxford Centre of Translational Myeloma Research and a fellow at St Catherine's College. His educational background includes a Diploma in Human Biology (1990) and PhD in Pharmacology and Toxicology (1994), both earned with distinctions from Philipps University Marburg. Prior academic appointments include Associate Professor at Karolinska Institutet (until 2004) and sabbatical work at Yale University. Research focuses on epigenetic mechanisms in disease through drug and target discovery using systems biology and single-cell approaches . Key disease targets include metabolic disorders, inflammatory conditions, and malignant diseases—particularly multiple myeloma and secondary bone cancers. His group pioneers chemical biology applications in primary tumor microenvironments. Current funding sources include Cancer Research UK, Innovate UK, EPSRC, Royal Society-Newton Fund, Bristol Myers Squibb, Bayer Healthcare, GlaxoSmithKline, Blood Cancer UK, and Leducq Foundation. Notable research trends show increasing emphasis on epigenetic regulation in immune cells (2020-2024), single-cell technologies for myeloma (2022-2024), and translational applications of chromatin modifiers (2016-2019). Recent work integrates metabolomics with epigenetic mechanisms in gynecological and hematological disorders. He supervises doctoral research including Singh K.'s 2024 thesis on sonodynamic therapy mechanisms. Leadership roles encompass directing Oxford's Molecular Laboratory Sciences division and co-leading translational myeloma research initiatives.

• Artificial intelligence
• Biomedical signal processing
• Human movement analysis
• +۱۲ مورد دیگر

Marco Ghislieri is an Assistant Professor at the Department of Electronics and Telecommunications (DET) of Politecnico di Torino, Italy. He is a member of the Interdepartmental Center PolitoBIOMed Lab and teaches in the Biomedical Engineering program, including courses like Neuroengineering and Design of Programmable Biomedical Devices . His research spans Artificial Intelligence, Biomedical Signal Processing, Neuroscience, and Rehabilitation Engineering . PhD in Bioengineering and Medical-Surgical Sciences (2017-2021) at Politecnico di Torino Thesis: Muscle Synergy Assessment during Cyclic and Non-Cyclic Movements His research focuses on muscle synergy analysis in Parkinson’s Disease (PD) patients post- Deep Brain Stimulation (DBS) , AI-driven gait analysis for fall prevention, and wearable sensor applications for stress-cognitive decline monitoring. He leads the S-CoDe and OMNIA-PARK projects, and contributes to PRIN as a team member. Recent publications highlight advancements in machine learning for intraoperative DBS targeting , statistical gait analysis , and neurorehabilitation tools . He serves as Associate Editor for Scientific Reports and Applied Bionics and Biomechanics , and Guest Editor for Frontiers in Neural Circuits . Awards include the Carlo J. De Luca Award (2022) , GNB Doctoral Award (2022) , and the Best Poster Award at M. Grattarola Summer School (2022) . He supervises Fabrizio Sciscenti (PhD candidate) and collaborates on neuroengineering and biomedical device design courses. His work addresses Goal 3 (Good Health) and Goal 4 (Quality Education) of the UN SDGs.

Helen Byrneمشاهده پروفایل

استاد

• Mathematical Biology
• Computational Biology
• Tumour Modeling
• +۵ مورد دیگر

Helen Byrne is a Professor of Applied Mathematics at the University of Oxford and a Tutorial Fellow at Keble College. Her academic roles include former Examiner for Final Honour School Mathematics, Associate Head of Department for Planning and Equality and Diversity, and Director of Equality and Diversity in the university’s MPLS Division. DPhil MSc BA/MA Her research focuses on developing mathematical and computational models to study biomedical systems, particularly solid tumours, wound healing, and tissue engineering. She aims to uncover mechanisms behind biological phenomena and derive novel mathematical insights from these models. Recent publications highlight her work in tumor-immune interactions, atherosclerosis, antibody dynamics, and radiation therapy, employing techniques like spatial modeling, agent-based simulations, and multiscale approaches. Her research bridges theoretical mathematics and practical biomedical challenges. 2019: Leah Edelstein-Keshet Prize (Senior Award), Society for Mathematical Biology 2020: Fellow of the Society for Mathematical Biology Helen Byrne has supervised numerous students and researchers, contributing to mathematical biology and biomedical modeling. Her teaching includes courses on multivariable calculus, applied partial differential equations, and advanced mathematical biology.

• Reproductive Medicine
• Fertility Preservation
• Ultrasound Imaging
• +۳ مورد دیگر

Dr. Yazan Abdallah is an Honorary Clinical Lecturer in the Department of Metabolism, Digestion and Reproduction at Imperial College London's Faculty of Medicine. He is a Consultant in Reproductive Medicine and Surgery at St Mary's Hospital, Manchester, with dual GMC accreditation in Obstetrics & Gynaecology and Reproductive Medicine. MD (2005), PhD (2014) H-index of 18 with over 30 peer-reviewed publications Specializes in fertility preservation for cancer survivors His research focuses on: Reproductive Medicine Ultrasound Imaging (3D, blood flow studies) Recurrent Miscarriage Diagnosis Uterine Transplantation Immune Suppression Cesarean Scar Analysis His work has led to international guideline changes (RCOG/NICE) and collaborations with KU Leuven. He has received the National Institute for Health Research (NIHR) Award and participated in the International Ovarian Tumor Analysis (IOTA) group. Recent publications analyze pregnancy outcomes, diagnostic ultrasound reproducibility, and fertility preservation in oncology.

Timothy D. O'Brienمشاهده پروفایل

استاد

• Veterinary Pathology
• Comparative Pathology
• Transplantation Biology
• +۴ مورد دیگر

Timothy D. O'Brien is a Professor and Division Head of Comparative Pathology in the Department of Veterinary Population Medicine at the University of Minnesota College of Veterinary Medicine. He holds multiple affiliations including the Stem Cell Institute, Masonic Cancer Center, and Institute for Engineering in Medicine. Dr. O'Brien also serves as faculty for the Masters Program in Stem Cell Biology. Dr. O'Brien earned his BS, DVM, and PhD degrees from the University of Minnesota in 1976, 1978, and 1985 respectively. He is a Diplomate of the American College of Veterinary Pathologists (Anatomic Pathology, 1984). His research spans veterinary pathology, transplantation biology, stem cell research, and cancer biology with a focus on comparative pathology models. He has made significant contributions to understanding interspecies organogenesis, islet xenotransplantation, and animal models for human diseases. His work bridges veterinary and human medicine, exploring translational applications of findings from animal models to human conditions. Recent publications highlight innovative approaches to transplantation without long-term immunosuppression and studies on hemangiosarcoma biology. Dr. O'Brien's publication record demonstrates expertise across multiple disciplines including diabetes research using feline models, lung cancer heterogeneity, and innovative transplantation techniques. His work frequently involves interdisciplinary collaborations across veterinary medicine, engineering, and human medical specialties, reflecting the integrative nature of modern biomedical research. His research program involves extensive collaborations across the University of Minnesota and beyond, working on projects related to stem cell biology, cancer research, and transplantation medicine. As Division Head of Comparative Pathology, he oversees diagnostic pathology services while maintaining an active research program that contributes to advancing our understanding of disease mechanisms through comparative approaches.

• Environmental Epidemiology
• Air Pollution
• Noise Pollution
• +۱۲ مورد دیگر

Zorana Jovanovic Andersen is an Associate Professor at the University of Copenhagen, Department of Public Health, Section of Environmental Health, specializing in Environmental and Occupational Epidemiology. Her research focuses on health impacts of air pollution , noise exposure , and lifestyle factors across large cohorts including the Danish Nurse Cohort and Diet, Health, and Cancer cohort. Primary research areas: Environmental Epidemiology, Breast Cancer Risk, Air Pollution, Noise Studies, Physical Activity Interactions Key projects: Hyperion (road traffic noise), ELAPSE (low-level air pollution), TAPAS (climate-transportation health risks) Research Themes She investigates long-term exposure to air pollution and noise in relation to breast cancer , diabetes , cardiovascular disease , and brain cancer , while exploring how factors like physical activity modify these risks. Recent work includes dementia and COVID-19 mortality analyses. Scientific Contributions Her 15 most recent publications address: 1) Air pollution disparities in Europe 2) Dementia-air pollution links 3) Stroke-noise interactions 4) Airport ultrafine particle exposure 5) Asthma-COPD overlap 6) Breast cancer-mammographic density relationships. Major Grants Danish Working Environment Research Fund (1.79M DKK, 2017) Danish Heart Association (433K DKK, 2016) Danish Council for Independent Research (1.93M DKK, 2015) Teaching & Leadership Course Leader for Data Processing in Health Care and Public Health Informatics at UCPH since 2011. Organized Danish Health Registries seminars and served on scientific committees for environmental conferences.

Huazhong Shiمشاهده پروفایل

استاد

• Biochemistry
• Molecular Biology
• Gene Editing
• +۳ مورد دیگر

Dr. Huazhong Shi is a Professor in the Department of Chemistry and Biochemistry at Texas Tech University. His research focuses on molecular biology, biochemistry, and plant stress response mechanisms, with a particular emphasis on gene editing for crop improvement, herbicide resistance development, and computational simulations of protein-small molecule interactions. Ph.D., Wuhan University, China, 1995 Research Associate, University of Arizona, 1999-2001 Research Associate, University of California, 2001-2003 Research Associate, Purdue University, 2003-2004 Dr. Shi’s research explores gene editing strategies to enhance crop traits such as clonal seed production, haploid induction, and herbicide resistance. His lab also investigates molecular dynamics simulations to understand enzyme-herbicide interactions and stress-inducible gene regulation. Key projects include engineering salt-tolerant crops via Na+/H+ antiporter optimization and elucidating the roles of SHI genes in stress response pathways. The 15 most recent publications highlight advancements in gene editing for hybrid vigor preservation, directed evolution of herbicide-resistant enzymes, and computational modeling of stress tolerance mechanisms. These works span disciplines including plant biotechnology, environmental toxicology, and agricultural sustainability, with subfields such as RNA splicing, redox biology, and nutrient-stress interactions. Dr. Shi’s lab includes graduate students Yihui Yuan, Hongjia Qian, Amna Aqdas, Karthik Kalvakuntla, and Shoumik Kundu, alongside research associate Dr. Jianfei Guo. His work contributes to global food security through biotechnological innovations in crop resilience to environmental stresses.

Aaron Youngمشاهده پروفایل

دانشیار

• Human Augmentation
• Wearable Robotics
• Assistive Devices
• +۷ مورد دیگر

Aaron Young is an Associate Professor in the Woodruff School of Mechanical Engineering at Georgia Institute of Technology and a program faculty member in the Biomedical Engineering School. He serves as Director of the Exoskeleton and Prosthetic Intelligent Controls (EPIC) Lab, focusing on robotic human augmentation through advanced control systems for prosthetics and exoskeletons. Education: Postdoctoral Fellow, University of Michigan (2014-2016) Ph.D., Northwestern University (2014) M.S., Northwestern University (2011) B.S., Purdue University (2009) Dr. Young's research addresses clinically viable control systems for wearable robotic devices, emphasizing intent recognition , EMG signal processing , and machine learning integration. His work targets mobility impairments from stroke, amputation, cerebral palsy, and neurological injuries, aiming to reduce metabolic costs, restore natural biomechanics, and enhance community ambulation. Key innovations include data-driven control frameworks , biomechanical terrain adaptation , and anthropometry-based personalization . His recent publications highlight advancements in deep learning for real-time biomechanics , EMG-informed joint estimation , and adaptive assistance systems . The EPIC Lab's facilities feature a terrain park with force plates , motion capture systems , and HumoTech simulation platforms for device testing. Scientific Awards: New Faces of Engineering (IEEE USA, 2017) Military Health System Team Award (2015) NSF Graduate Fellowship (2010) NDSEG Fellowship (2010) IEEE EMBC 3rd Place (2013) Projects include NSF-funded hip exoskeletons for stroke survivors, DoD-powered prostheses for amputees, and Pediatric knee exoskeletons for cerebral palsy. The lab cultivates interdisciplinary expertise in robotics , biomedical engineering , and human-machine interaction .

• Tumor Glycocalyx Targeting
• Protease-Activated Anticancer Prodrugs
• Cancer Drug Development
• +۴ مورد دیگر

Robert Falconer serves as Professor of Medicinal Chemistry and Director of the Institute of Cancer Therapeutics (ICT) at the University of Bradford. A registered pharmacist with the General Pharmaceutical Council, he leads a multidisciplinary research team focused on tumor glycocalyx targeting and protease-activated anticancer prodrugs. His academic journey spans from pharmacy training at The School of Pharmacy, University of London to establishing the medicinal chemistry program at ICT in 2005. Pharmacy Degree: The School of Pharmacy, University of London (now UCL School of Pharmacy) PhD in Medicinal Chemistry: London (2000) Professional Registration: General Pharmaceutical Council Professor Falconer's research centers on tumor glycocalyx modulation through polysialyltransferase inhibition and protease-activated drug delivery systems. His work spans osteosarcoma, neuroblastoma, breast, and prostate cancers with emphasis on developing targeted therapies that minimize systemic toxicity. The Falconer group employs computational design, solid-phase synthesis, and advanced biological evaluation techniques to develop novel anticancer agents. His publication portfolio demonstrates consistent focus on tumor-specific activation mechanisms (2023-2025), glycocalyx-targeted metastasis inhibition (2019-2021), and prodrug development (2010-2014). Recent work emphasizes theranostic applications and DNA repair targeting for pediatric cancers. Fellow of the Royal Society of Chemistry Former Honorary Treasurer, RSC Central Yorkshire Local Section Trust (2012-2018) Registered Pharmacist with General Pharmaceutical Council As principal investigator, Falconer has secured substantial funding from Breast Cancer Now, Bone Cancer Research Trust, Worldwide Cancer Research, and Neuroblastoma UK. He leads the £2m ICT Doctoral Training Centre and co-founded spin-out company Incanthera plc, which is advancing the MMP-targeted prodrug ICT2588 to clinical trials. His mentorship includes three PhD students and multiple postdoctoral researchers developing next-generation cancer therapeutics. The Falconer group operates within the ICT's state-of-the-art facilities, collaborating with Stanford University, University of Sheffield, and Ellipses Pharma. Current projects address unmet needs in pediatric oncology while developing platform technologies applicable across multiple cancer types.

Lee Fergusonمشاهده پروفایل

استاد

• Environmental Analytical Chemistry
• High-Resolution Mass Spectrometry
• Per- and Polyfluoroalkyl Substances (PFAS)
• +۳ مورد دیگر

Lee Ferguson is a Professor of Civil and Environmental Engineering at Duke University, with additional appointments as Associate Professor in the Division of Marine Science and Policy. His research focuses on environmental analytical chemistry, particularly using high-resolution mass spectrometry to study per- and polyfluoroalkyl substances (PFAS) , microplastics , and endocrine disruptors . Ferguson Lab develops methods for contaminant detection in water systems and investigates chemical leaching from polymers. Ph.D. in Chemistry from Stony Brook University (2002) Former Assistant Professor at University of South Carolina (2003-2009) Recent work includes PFAS analysis in lithium-ion batteries, glyphosate detection in hard waters, and microplastic dye toxicity studies. Key publications explore urban watershed contamination, Sri Lankan drinking water CKDu links, and novel analytical methods for environmental pollutants. Applied Research Fellowship (2022), Kavli Frontiers of Science Fellow (2011) Testified before U.S. Senate on nanotechnology risks Co-founder of NC PFAS Testing Network As an advisor, he mentors Doctoral Candidates Patrick Faught and Anna Lewis , who investigate microplastic dyes and polymer additives. Lab research spans environmental fate of nanomaterials, contaminant bioavailability, and exposomics for health outcomes.

• Environmental Epidemiology
• Chronic Diseases
• Air Pollution
• +۳ مورد دیگر

Dr. Francine Laden is a renowned Professor of Environmental Epidemiology at the Harvard T.H. Chan School of Public Health , where she serves as Associate Chair of the Department of Environmental Health and Director of the NIH/NIEHS T32 Training Program in Environmental Epidemiology. She concurrently holds the title of Associate Professor of Medicine at Harvard Medical School and Brigham & Women’s Hospital. Her research program bridges environmental exposures with chronic disease epidemiology. ScD in Epidemiology and MS in Environmental Health from Harvard T.H. Chan School of Public Health Past President of the International Society of Environmental Epidemiology Former member of the EPA Science Advisory Board Dr. Laden's research focuses on environmental determinants of chronic diseases , including cancer, cardiovascular conditions, and respiratory illnesses. Her work systematically examines air pollution (ambient and occupational), persistent organic pollutants, secondhand smoke, temperature variations, and built/green environments using geographic information systems and large cohort studies such as the Nurses’ Health Study series and Health Professional Follow-Up Study. Recent publications demonstrate her expertise in environmental mixture effects on health outcomes, including air pollution and diabetes, greenspace and mental health, and noise exposure and hypertension. Her methodological innovations span digital phenotyping , spatial analysis , and multi-exposure modeling across life stages. 2023 John Goldsmith Award 2022 Marianne Wessling-Resnick Mentoring Award 2019 John A. Rock Scholar honorarium 2011 Alice Hamilton Lectureship As principal investigator on multiple NIH grants, Dr. Laden leads studies on environmental and social determinants of mammographic features , early-life exposure impacts on hypertension , and multi-stressor health disparities . She mentors through the T32 training program and collaborates across institutions on cardiovascular and ecological health research initiatives.

Andrew Murrayمشاهده پروفایل

استاد

• Evolutionary Biology
• Genetics
• Synthetic Biology
• +۹ مورد دیگر

Andrew Murray is a Professor at Harvard University, affiliated with the Rowland Institute and Department of Molecular and Cellular Biology. His research focuses on evolutionary biology, genetics, and synthetic biology using budding yeast as a model organism. Primary Affiliation: Harvard University Lab: Murray Lab Collaboration: with David Nelson (Physics/MBI) Research interests include: Evolution of biological novelty through experimental evolution Cellular mechanisms for environmental adaptation Quantitative analysis of evolutionary trajectories Engineering yeast strains to test biological principles Publications span evolutionary genetics, cell biology, and biophysics with recent work on ABC transporters and yeast colony dynamics. Collaborative clinical publications also exist in cardiology and surgical outcomes. Scientific recognition includes the John Harvard Distinguished Science Fellowship .